• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines.

作者信息

Stehlin Florian, Tommasini Francesco, Monzambani-Banderet Véronique, Girard Cedric, Yerly Daniel, Ribi Camillo, Muller Yannick D

机构信息

Division of Immunology and Allergy, University Hospital of Lausanne, Lausanne, Switzerland.

Pharmacy, University Hospital of Lausanne, Hospital and University of Lausanne, Lausanne, Switzerland.

出版信息

Allergol Int. 2023 Apr;72(2):332-334. doi: 10.1016/j.alit.2022.10.001. Epub 2022 Oct 22.

DOI:10.1016/j.alit.2022.10.001
PMID:36280516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9595453/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ca/9595453/bb8822d3d665/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ca/9595453/bb8822d3d665/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ca/9595453/bb8822d3d665/gr1_lrg.jpg

相似文献

1
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines.对mRNA SARS-CoV-2疫苗有速发型反应风险的成年人进行分级剂量免疫接种。
Allergol Int. 2023 Apr;72(2):332-334. doi: 10.1016/j.alit.2022.10.001. Epub 2022 Oct 22.
2
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
3
Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety Network.在加拿大国家疫苗安全网络中，有既往严重急性呼吸综合征冠状病毒 2 感染史的个体接种 mRNA 和病毒载体疫苗后的不良反应。
Clin Infect Dis. 2023 Mar 21;76(6):1088-1102. doi: 10.1093/cid/ciac852.
4
Myocarditis After BNT162b2 and mRNA-1273 Vaccination.接种 BNT162b2 和 mRNA-1273 后心肌炎。
Circulation. 2021 Aug 10;144(6):506-508. doi: 10.1161/CIRCULATIONAHA.121.055913. Epub 2021 Jun 16.
5
Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine.4 例接种 mRNA BNT162b2 SARS-CoV-2 疫苗后获得性血友病 A。
Thromb Res. 2022 Mar;211:60-62. doi: 10.1016/j.thromres.2022.01.017. Epub 2022 Jan 20.
6
Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity.3例接种新型冠状病毒mRNA疫苗后的皮肤不良反应：严重程度不一。
CMAJ. 2022 Jun 13;194(23):E807-E811. doi: 10.1503/cmaj.220435.
7
Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.川崎病病史患者对 COVID-19 感染和信使 RNA 疫苗接种的耐受性。
JAMA Netw Open. 2022 Aug 1;5(8):e2226236. doi: 10.1001/jamanetworkopen.2022.26236.
8
Acute urticaria alone after CoronaVac COVID-19 vaccination should not be a contraindication for revaccination.康希诺新冠病毒疫苗（CoronaVac）接种后仅出现急性荨麻疹不应成为再次接种的禁忌证。
Clin Exp Dermatol. 2022 Apr;47(4):735-738. doi: 10.1111/ced.14962. Epub 2021 Nov 11.
9
Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines.接种新冠病毒mRNA疫苗后出现嗜酸性粒细胞增多症。
J Allergy Clin Immunol Pract. 2023 May;11(5):1564-1566. doi: 10.1016/j.jaip.2023.01.024. Epub 2023 Jan 30.
10
A case of multisystem inflammatory syndrome in adults following natural infection and subsequent immunization.成人自然感染后再接种疫苗引发的多系统炎症综合征病例
Int J Infect Dis. 2022 Mar;116:34-37. doi: 10.1016/j.ijid.2021.12.339. Epub 2021 Dec 24.

引用本文的文献

1
Features of chronic urticaria after COVID-19 mRNA vaccine over time.新冠mRNA疫苗接种后慢性荨麻疹随时间变化的特征
Commun Med (Lond). 2024 Nov 30;4(1):254. doi: 10.1038/s43856-024-00656-y.

本文引用的文献

1
Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.新冠病毒 mRNA 疫苗皮内试验可预测耐受性。
Front Allergy. 2022 May 31;3:818049. doi: 10.3389/falgy.2022.818049. eCollection 2022.
2
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.新型冠状病毒疫苗二次过敏反应风险：系统评价和荟萃分析。
JAMA Intern Med. 2022 Apr 1;182(4):376-385. doi: 10.1001/jamainternmed.2021.8515.
3
Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper.过敏与 COVID-19 疫苗：ENDA/EAACI 立场文件。
Allergy. 2022 Aug;77(8):2292-2312. doi: 10.1111/all.15241. Epub 2022 Mar 5.
4
Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.聚乙二醇过敏导向的 COVID-19 疫苗过敏反应风险管理经验。
Allergy. 2022 Jul;77(7):2200-2210. doi: 10.1111/all.15183. Epub 2021 Dec 4.
5
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.mRNA COVID-19 疫苗首剂过敏反应：赋形剂皮肤试验作用有限。
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3308-3320.e3. doi: 10.1016/j.jaip.2021.06.010. Epub 2021 Jun 22.
6
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.新型冠状病毒疫苗过敏反应风险及推荐评估和管理：系统评价、荟萃分析、GRADE 评估和国际共识方法。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3546-3567. doi: 10.1016/j.jaip.2021.06.006. Epub 2021 Jun 18.
7
Optimizing investigation of suspected allergy to polyethylene glycols.优化对疑似聚乙二醇过敏的调查。
J Allergy Clin Immunol. 2022 Jan;149(1):168-175.e4. doi: 10.1016/j.jaci.2021.05.020. Epub 2021 May 28.
8
Polyethylene Glycol-Induced Systemic Allergic Reactions (Anaphylaxis).聚乙二醇引起的全身性过敏反应（过敏症）。
J Allergy Clin Immunol Pract. 2021 Feb;9(2):670-675. doi: 10.1016/j.jaip.2020.09.029. Epub 2020 Oct 1.
9
Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients.102 例患者中序列血清类胰蛋白酶对过敏反应诊断的作用及局限性。
Int Arch Allergy Immunol. 2013;160(2):192-9. doi: 10.1159/000339749. Epub 2012 Sep 25.
10
An algorithm for treatment of patients with hypersensitivity reactions after vaccines.一种用于治疗疫苗接种后过敏反应患者的算法。
Pediatrics. 2008 Sep;122(3):e771-7. doi: 10.1542/peds.2008-1002.